18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging-Reference-Cited by-同舟云学术

18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging

Published:2017-10 Issue:10 Volume:39 Page:101042831772828
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumour Biol.

Author:

Caresia Aroztegui Ana Paula¹,García Vicente Ana María²,Alvarez Ruiz Soledad³,Delgado Bolton Roberto Carlos⁴,Orcajo Rincon Javier⁵,Garcia Garzon Jose Ramon⁶,de Arcocha Torres Maria⁷,Garcia-Velloso Maria Jose⁸

Affiliation:

1. Department of Nuclear Medicine, Hospital Parc Taulí, Sabadell, Spain

2. Department of Nuclear Medicine, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

3. Department of Nuclear Medicine, Hospital Universitario Miguel Servet, Zaragoza, Spain

4. Department of Diagnostic Imaging and Nuclear Medicine, Hospital San Pedro—Centro de Investigación Biomédica de La Rioja (CIBIR), Logroño, Spain

5. Department of Nuclear Medicine, Hospital General Universitario Gregorio Marañón, Madrid, Spain

6. PET/CT Unit, CETIR-ERESA, Esplugues de Llobregat, Spain

7. Radiopharmacy Unit, Hospital Universitario Marques de Valdecilla, Santander, Spain

8. Department of Nuclear Medicine, Clínica Universidad de Navarra, Pamplona, Spain

Publisher

IOS Press

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1010428317728285

Reference59 articles.

1. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women

2. Breast cancer survival in the US and Europe: A CONCORD high-resolution study

3. SEOM clinical guidelines in metastatic breast cancer 2015

4. SEOM clinical guidelines in early-stage breast cancer 2015

5. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of serum lactate dehydrogenase with prognosis and tumor metabolism in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab therapy;Surgery Today;2024-08-04

2. Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-14

3. Breast Cancer Subtype Prediction Model Employing Artificial Neural Network and 18F-Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography;Journal of Medical Physics;2024-04

4. Initial Clinical Experience using 68Ga-FAPI-46 PET/CT for Detecting Various Cancer Types;2023-10-06

5. Imaging Recommendations for Positron Emission Tomography (PET) in Oncology;Indian Journal of Medical and Paediatric Oncology;2023-05-12